Literature DB >> 21169543

IL-2-controlled expression of multiple T cell trafficking genes and Th2 cytokines in the regulatory T cell-deficient scurfy mice: implication to multiorgan inflammation and control of skin and lung inflammation.

Rahul Sharma1, Poonam R Sharma, Young-Chul Kim, Norbert Leitinger, Jae K Lee, Shu Man Fu, Shyr-Te Ju.   

Abstract

Scurfy (Sf) mice bear a mutation in the Foxp3 transcription factor, lack regulatory T cells (Treg), develop multiorgan inflammation, and die prematurely. The major target organs affected are skin, lungs, and liver. “Sf mice lacking the Il2 gene (Sf.Il2–/–), despite being devoid of Treg, did not develop skin and lung inflammation, but the inflammation in liver remained [corrected]. Genome-wide microarray analysis revealed hundreds of genes that were differentially regulated among Sf, Sf.Il2(-/-), and B6 CD4(+) T cells, but the most significant changes were those encoding receptors for trafficking/chemotaxis/retention and cytokines. Our study suggests that IL-2 controls the skin and lung inflammation in Sf mice in an apparent "organ-specific" manner through two novel mechanisms: by regulating the expression of genes encoding a variety of receptors for T cell trafficking/chemotaxis/retention and by regulating Th2 cell expansion and cytokine production. Thus, IL-2 is potentially a master regulator for multiorgan inflammation and an underlying etiological factor for various diseases associated with skin and lung inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21169543      PMCID: PMC3136806          DOI: 10.4049/jimmunol.1002677

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

1.  Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-gamma on peripheral immune cells.

Authors:  S Brandon Early; Elizabeth Barekzi; Julie Negri; Kathleen Hise; Larry Borish; John W Steinke
Journal:  Am J Respir Cell Mol Biol       Date:  2007-02-01       Impact factor: 6.914

2.  Th2 differentiation in distinct lymph nodes influences the site of mucosal Th2 immune-inflammatory responses.

Authors:  David Alvarez; Janine L Arkinson; Jiangfeng Sun; Ramzi Fattouh; Tina Walker; Manel Jordana
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

3.  Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.

Authors:  Jeong M Kim; Jeffrey P Rasmussen; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2006-11-30       Impact factor: 25.606

Review 4.  CXCR2--the receptor to hit?

Authors:  Jörg Reutershan
Journal:  Drug News Perspect       Date:  2006-12

5.  A regulatory T cell-dependent novel function of CD25 (IL-2Ralpha) controlling memory CD8(+) T cell homeostasis.

Authors:  Rahul Sharma; Lingjie Zheng; Umesh S Deshmukh; Wael N Jarjour; Sun-Sang J Sung; Shu Man Fu; Shyr-Te Ju
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

6.  Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations.

Authors:  Elisabetta Capriotti; Eric C Vonderheid; Christopher J Thoburn; Emilie C Bright; Allan D Hess
Journal:  J Invest Dermatol       Date:  2007-06-28       Impact factor: 8.551

7.  Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes.

Authors:  Hideaki Shirasaki; Nobuhiko Seki; Manabu Fujita; Megumi Kikuchi; Etsuko Kanaizumi; Kazumasa Watanabe; Tetsuo Himi
Journal:  Ann Allergy Asthma Immunol       Date:  2007-10       Impact factor: 6.347

8.  Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin.

Authors:  Felix Scholz; Alexander Schulte; Frederic Adamski; Christian Hundhausen; Jens Mittag; Agatha Schwarz; Marie-Luise Kruse; Ehrhardt Proksch; Andreas Ludwig
Journal:  J Invest Dermatol       Date:  2007-03-15       Impact factor: 8.551

9.  Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration.

Authors:  Paul Proost; Anneleen Mortier; Tamara Loos; Jo Vandercappellen; Mieke Gouwy; Isabelle Ronsse; Evemie Schutyser; Willy Put; Marc Parmentier; Sofie Struyf; Jo Van Damme
Journal:  Blood       Date:  2007-03-15       Impact factor: 22.113

10.  A novel role of IL-2 in organ-specific autoimmune inflammation beyond regulatory T cell checkpoint: both IL-2 knockout and Fas mutation prolong lifespan of Scurfy mice but by different mechanisms.

Authors:  Lingjie Zheng; Rahul Sharma; Felicia Gaskin; Shu Man Fu; Shyr-Te Ju
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

View more
  31 in total

1.  A novel function of IL-2: chemokine/chemoattractant/retention receptor genes induction in Th subsets for skin and lung inflammation.

Authors:  Rahul Sharma; Sun-Sang J Sung; Felicia Gaskin; Shu Man Fu; Shyr-Te Ju
Journal:  J Autoimmun       Date:  2012-03-29       Impact factor: 7.094

2.  IL-2: a two-faced master regulator of autoimmunity.

Authors:  Rahul Sharma; Shu Man Fu; Shyr-Te Ju
Journal:  J Autoimmun       Date:  2011-02-01       Impact factor: 7.094

3.  IL233, an IL-2-IL-33 hybrid cytokine induces prolonged remission of mouse lupus nephritis by targeting Treg cells as a single therapeutic agent.

Authors:  Marta E Stremska; Chao Dai; Rajkumar Venkatadri; Hongyang Wang; Vikram Sabapathy; Gaurav Kumar; Sheethal Jose; Saleh Mohammad; Sun-Sang J Sung; Shu Man Fu; Rahul Sharma
Journal:  J Autoimmun       Date:  2019-05-15       Impact factor: 7.094

Review 4.  Opposing functions of IL-2 and IL-7 in the regulation of immune responses.

Authors:  Shoshana D Katzman; Katrina K Hoyer; Hans Dooms; Iris K Gratz; Michael D Rosenblum; Jonathan S Paw; Sara H Isakson; Abul K Abbas
Journal:  Cytokine       Date:  2011-07-31       Impact factor: 3.861

5.  IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal Injury.

Authors:  Marta E Stremska; Sheethal Jose; Vikram Sabapathy; Liping Huang; Amandeep Bajwa; Gilbert R Kinsey; Poonam R Sharma; Saleh Mohammad; Diane L Rosin; Mark D Okusa; Rahul Sharma
Journal:  J Am Soc Nephrol       Date:  2017-05-24       Impact factor: 10.121

6.  Systemic Activation of NRF2 Alleviates Lethal Autoimmune Inflammation in Scurfy Mice.

Authors:  Takuma Suzuki; Shohei Murakami; Shyam S Biswal; Shimon Sakaguchi; Hideo Harigae; Masayuki Yamamoto; Hozumi Motohashi
Journal:  Mol Cell Biol       Date:  2017-07-14       Impact factor: 4.272

7.  Type-1 immunity drives early lethality in scurfy mice.

Authors:  Todd J Suscovich; Nikole R Perdue; Daniel J Campbell
Journal:  Eur J Immunol       Date:  2012-07-25       Impact factor: 5.532

8.  Structure and function of ameloblastin as an extracellular matrix protein: adhesion, calcium binding, and CD63 interaction in human and mouse.

Authors:  Xu Zhang; Thomas G H Diekwisch; Xianghong Luan
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

Review 9.  T cell subsets: an integral component in pathogenesis of rheumatic heart disease.

Authors:  Devinder Toor; Neha Sharma
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

Review 10.  Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful.

Authors:  K Kai McKinstry; Richard W Dutton; Susan L Swain; Tara M Strutt
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-05-25       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.